Filing Details

Accession Number:
0001127602-12-026197
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-09-12 14:23:56
Reporting Period:
2012-09-11
Filing Date:
2012-09-12
Accepted Time:
2012-09-12 14:23:56
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
799729 Parexel International Corp PRXL Services-Commercial Physical & Biological Research (8731) 042776269
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1266051 J Christopher Lindop Haemonetics Corporation
400 Wood Road
Braintree MA 02184-9114
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2012-09-11 7,800 $30.10 40,355 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The reported sale was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the reporting person.
  2. This transaction was executed in multiple trades through a trade order executed by a broker-dealer at prices ranging from $29.97- $30.23. The price reported in this column reflects the weighted average sale price. For all transactions reported on this Form 4 utilizing a weighted average sale price, the reporting person will provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each price.